Clin2
NCT06082765Possibly a fitRecruiting

Cervical cancer screening with menstrual blood test

Cervical Cancer

Part of Cancer, Women’s health & pregnancy clinical trials.

This trial tests if a new DNA test (NGS-HPV) using menstrual blood can detect HPV and help screen for cervical cancer. You may participate if you have regular periods and plan to get cervical screening.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
20 years to 60 years
Study type
Observational

Who can take part

  • You plan to have cervical cancer screening
  • You have regular periods every 21 to 35 days
  • You are not in menopause or have stopped having periods
  • You do not have an active infection in your genital tract
  • You agree to join the study and sign a consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07214584Recruiting
Using blood and cervical tests to track cervical cancer treatment response

This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.

Gainesville, Florida
NCT07593066Not yet recruiting
Cervical cancer screening study for women

This study looks at ways to improve cervical cancer screening for women. If you join, you may help researchers find better methods for early detection, which can lead to earlier treatment and better outcomes.

Coyhaique, Aysén
NCT05774561Recruiting
Using blood tests to monitor HPV-related cancer treatment

This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.

Olomouc
NCT04743674Recruiting
Blood and urine tests to track cervical cancer after treatment

This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.

Chapel Hill, North Carolina
NCT06042543Recruiting
Cervical cancer screening trial for unscreened women

This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.

Cincinnati, Ohio
NCT05606133Recruiting
Test HPV DNA from blood to track cervical cancer risk

This study looks at a blood test that measures HPV DNA to help screen and monitor people with HPV-related cervical problems. If you have confirmed high-grade cervical changes or cervical cancer, the test may help doctors follow how your condition changes over time.

New York, New York

Hear when a new Cervical Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.